The 20 Best Head and Neck Squamous Cell Carcinoma (HNSCC) Doctors Near Me

Joseph Curry is an Otolaryngologist and a General Surgeon in Philadelphia, Pennsylvania. Dr. Curry is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Duct Stones, Throat Cancer, Laryngectomy, and Gastrostomy. Dr. Curry is currently accepting new patients.

Dan P. Zandberg, MD, is an associate professor of medicine and a medical oncologist/hematologist, specializing in the treatment of head and neck and thyroid cancers. He is the Director of the Head and Neck and Thyroid Cancer disease sections for the division of Hematology/Oncology and the Medical Oncology Co-Leader of the UPMC Hillman Head and Neck Cancer Program. He is also the physician lead for the second floor Hillman Cancer Center clinic. His main research focus is in the development of clinical trials with immunotherapy to improve patient outcomes. Recent awards include the 2019 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award, 2020 Leo Criep, M.D. Excellence in Patient Care Award, and 2020/2021 Castle Connolly Regional Top Doctor. Dr. Zandberg is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Small Cell Lung Cancer (SCLC), and ALK-Positive Non-Small Cell Lung Cancer.

Adam Luginbuhl is an Otolaryngologist in Philadelphia, Pennsylvania. Dr. Luginbuhl is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Throat Cancer, Laryngectomy, and Gastrostomy. Dr. Luginbuhl is currently accepting new patients.

David Cognetti is an Otolaryngologist in Philadelphia, Pennsylvania. Dr. Cognetti is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Duct Stones, Sialadenitis, Laryngectomy, and Gastrostomy. Dr. Cognetti is currently accepting new patients.

Dr. Seungwon Kim is chief of the Division of Head and Neck Surgery and an associate professor in the Department of Otolaryngology at the University of Pittsburgh School of Medicine. Dr. Kim has received his board certification in Otolaryngology–Head and Neck Surgery. Dr. Kim received his medical degree from the State University of New York at Syracuse. He completed a residency in the Department of Otolaryngology–Head and Neck Surgery at the State University of New York at Syracuse. Afterwards, he completed a Research Fellowship in Head and Neck Surgical Oncology and a clinical fellowship in the Department of Head and Neck Surgery at U.T.M.D. Anderson Cancer Center in Houston, Texas. Dr. Kim is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Gastrostomy.

Conor Steuer is an Oncologist in Atlanta, Georgia. Dr. Steuer has been practicing medicine for over 17 years and is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Lung Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Tissue Biopsy, and Gastrostomy.

José P. Zevallos, MD, MPH, is the Eugene N. Myers, M.D. Chairman of Otolaryngology at the University of Pittsburgh Medical Center (UPMC).  Dr. Zevallos received his medical degree from Rutgers University and completed his residency at Baylor College of Medicine in Houston, Texas. From there, he went on to do a fellowship in Head and Neck Oncology and Microvascular Reconstruction at Beth Israel Mount Sinai Hospital in New York City.  Prior to this position, he served as Division Chief of Head and Neck Surgery at Washington University School of Medicine and the Siteman Cancer Center in St. Louis, Missouri. Dr. Zevallos is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Laryngectomy, and Thyroidectomy.

Heath D. Skinner, MD, PhD, is chair and medical director of the Department of Radiation Oncology and professor at UPMC Hillman Cancer Center, specializing in the study and treatment of head and neck and lung cancer. Dr. Skinner's research is designed to generate insights that led to the rational design of clinical trials using agents that are currently under investigation to minimize the time from bench to bedside.Dr. Skinner is board-certified in radiation oncology. He completed a combined MD/PhD program at West Virginia University. Upon completion of medical school, he began a combined internship and residency in radiation oncology at the University of Texas MD Anderson Cancer Center (MDACC).Over the course of his career, Dr. Skinner has received eight peer-reviewed grants, including a two current R01s funding his research. He has published over 85 peer-reviewed articles , has written 6 book chapters and 9 invited reviews and presented over 50 abstracts at national meetings. Dr. Skinner has also been invited to present his work at multiple domestic and international symposia.In addition to his research, Dr. Skinner is dedicated to providing excellent and compassionate patient care. This dedication is borne out in patient experience measures, with his scores being almost uniformly in the 99th percentile for all categories asked. Moreover, his patients have rated him in the top 1 percent nationally on Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS) measures related to their experience with him in his clinic. Dr. Skinner is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Esophageal Cancer, Anaplastic Thyroid Cancer, Lung Cancer, and Gastrostomy.

Nabil Saba is an Oncologist in Atlanta, Georgia. Dr. Saba has been practicing medicine for over 36 years and is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngeal Cancer, Throat Cancer, Glossectomy, and Tissue Biopsy.

Dr. Ravi Uppaluri, MD/PhD is a Professor of Otolaryngology-Head and Neck Surgery at Harvard Medical School and head and neck surgeon at Brigham and Women’s Hospital. He is board certified by the American Board of Otolaryngology-Head and Neck Surgery. His clinical interests include minimally invasive head and neck surgery including endoscopic approaches for skull base tumors and transoral laser removal of head and neck cancers, thyroid surgery and salivary gland/ parotid tumor management. To help manage these complex conditions, Dr. Uppaluri works in a close, multidisciplinary fashion with colleagues in neurosurgery, plastic surgery, medical and radiation oncology.   Dr. Uppaluri completed his medical school and obtained a doctorate in molecular genetics at the University of Minnesota. He subsequently trained in Otolaryngology- Head and Neck Surgery at Washington University and Barnes-Jewish Hospital in St. Louis, MO. He remained as a faculty there for 16 years prior to moving to Boston in 2016. Dr. Uppaluri is the chief of head and neck surgical oncology at the Dana-Farber and Brigham and Women’s Cancer Center, and Chief of the Division of Otolaryngology within the Department of Surgery at Brigham and Women’s Hospital.  Dr. Uppaluri’s research interests focus on basic and translational approaches to improving outcomes for patients with head and neck cancers. He leads an NIH funded laboratory focused on immunotherapy (NIH/NIDCR R01 “Immunotherapeutic responses to neoantigens in head and neck cancer” and NIH/NCI/NIDCR U01 “Defining immunotherapy resistance mechanisms in head and neck cancer”). He also has been the leader of clinical trials integrating novel therapeutics into the surgical management of head and neck cancers (ClinicalTrials.gov NCT02296684). Dr. Uppaluri is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, Tongue Cancer, Osteotomy, and Thyroidectomy.

Dr. Jonas Johnson is a professor of otolaryngology and radiation oncology at the University of Pittsburgh School of Medicine Department of Otolaryngology and a professor of oral and maxillofacial surgery at the University of Pittsburgh School of Dental Medicine. In addition, he has been named as a top doctor in America by Castle Connolly Medical Ltd. Dr. Johnson has received many awards for his teaching and medical accomplishments and is a past president of both the American Academy of Otolaryngology–Head and Neck Surgery and the American Head and Neck Society. Dr. Johnson is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Swallowing Difficulty, Throat Cancer, Laryngectomy, and Glossectomy.

Wayne Koch is a national and international leader in head and neck oncologic surgery, caring for patients with cancers of the oral cavity, salivary gland, larynx, hypopharynx, oropharynx and thyroid. Among Dr. Koch's landmark publications are studies demonstrating how key molecular events such as p53 mutation and human papillomavirus (HPV) contribute to the development of head and neck cancer. His peer-reviewed publications include six articles in the New England Journal of Medicine. Dr. Koch is also involved in humanitarian outreach focused on training surgeons in several African nations. He has served as president of the American Head and Neck Society, the national organization of head and neck cancer surgeons in the USA. Dr. Koch is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Human Papillomavirus Infection, Laryngectomy, and Gastrostomy.

Vassiliki Saloura is an Otolaryngologist and an Oncologist in Baltimore, Maryland. Dr. Saloura is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Wolf-Hirschhorn Syndrome, Glioma, and Tongue Cancer.

Maie John is an Otolaryngologist in Baltimore, Maryland. Dr. John is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). Her top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy.

Dr. Carole Fakhry is a head and neck surgical oncologist at Johns Hopkins and treats the breadth of patients with head and neck cancers, including cancers of the tonsils, base of tongue, mouth, larynx, thyroid, salivary gland (parotid, submandibular gland) and skin cancers among others. She is the Chief of the Division of Head and Neck Surgery and Director of the Head and Neck Cancer Center. She also serves as director of the head and neck group in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the head and neck surgical oncology fellowship. She is the associate editor for Oral Oncology and serves on several editorial boards. After an undergraduate degree at Stanford University, she completed medical school, residency in otolaryngology head and neck surgery, and a fellowship in head and neck surgical oncology at Johns Hopkins. She has also received a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She is presently a professor in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Oncology, and Johns Hopkins Bloomberg School of Public Health Department of Epidemiology. Her research interest focuses on the role of human papillomavirus (HPV) in head and neck squamous cell cancer. She has demonstrated that the presence of HPV confers a prognostic advantage to individuals with oropharyngeal cancer and that HPV is associated with unique clinical characteristics. In addition to the clinical implications of HPV in head and neck cancer, she is co-principal investigator of a large study to understand screening individuals at “high risk” of malignancy and evaluating imaging modalities to improve diagnostics and early detection of HPV- related head and neck cancer. Dr. Fakhry is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). Her top areas of expertise are Human Papillomavirus Infection, Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, Laryngectomy, and Gastrostomy.

Matthew E. Spector, MD, FACS, completed his medical school training at Stritch School of Medicine, Loyola University in Chicago. He then went on to the University of Michigan where he completed his residency in Otolaryngology – Head and Neck Surgery and fellowship in Head and Neck Surgical Oncology and Microvascular Reconstruction. He was on faculty at the University of Michigan for 10 years where he served as the Director of the Head and Neck Oncology Program and Associate Director of the Head and Neck Surgical Oncology and Microvascular Reconstruction Fellowship. Dr. Spector is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Glossectomy.

Dong Shin is an Oncologist in Atlanta, Georgia. Dr. Shin has been practicing medicine for over 51 years and is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Laryngeal Cancer, Tissue Biopsy, and Gastrostomy.

Shlomo Koyfman is an Otolaryngologist in Cleveland, Ohio. Dr. Koyfman has been practicing medicine for over 24 years and is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Laryngeal Cancer, Throat Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Laryngectomy, and Thyroidectomy.

Ammar Sukari is an Oncologist in Detroit, Michigan. Dr. Sukari has been practicing medicine for over 27 years and is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Nasopharyngeal Carcinoma, and Gastrostomy. Dr. Sukari is currently accepting new patients.

Loren Michel is a Hematologist and an Oncologist in Basking Ridge, New Jersey. Dr. Michel is rated as an Elite provider by MediFind in the treatment of Head and Neck Squamous Cell Carcinoma (HNSCC). His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, Adenoid Cystic Carcinoma, and Epithelial-Myoepithelial Carcinoma. Dr. Michel is currently accepting new patients.